RespiratoryTier 2Topic

Effects of common comorbid conditions, obesity, and metabolic syndrome on the respiratory system

Overview

Several common systemic conditions produce characteristic effects on respiratory mechanics and function, independent of primary lung disease
Increasingly relevant given rising obesity prevalence and an ageing population with multiple comorbidities

Effects by condition

Condition	Respiratory effect
Obesity	Reduced chest wall/lung compliance, reduced FRC and ERV, V/Q mismatch (basal atelectasis), risk of obesity hypoventilation syndrome
Neuromuscular disease (MND, myasthenia, muscular dystrophy)	Restrictive pattern from respiratory muscle weakness - reduced VC, impaired cough, risk of aspiration and nocturnal hypoventilation
Connective tissue disease (systemic sclerosis, RA, SLE)	ILD, pulmonary hypertension, pleural disease - each CTD has a characteristic pattern
Kyphoscoliosis	Restrictive defect from chest wall deformity

Testing

Pulmonary function testing pattern (restrictive vs obstructive vs mixed) plus the systemic clinical context localises the mechanism
Supine vs erect spirometry difference is a specific clue to diaphragmatic weakness

Management

Treat the underlying systemic condition
Nocturnal non-invasive ventilation for progressive neuromuscular respiratory weakness (e.g. MND) - a key quality-of-life and prognosis-modifying intervention

Associations

Obesity hypoventilation syndrome, motor neuron disease, systemic sclerosis-associated ILD, kyphoscoliosis

Key point

Respiratory muscle weakness often precedes overt respiratory failure by months - proactive monitoring (vital capacity trend) in progressive neuromuscular disease anticipates the need for NIV before a crisis

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.

Get premium access